Predictors of CPAP failure after less-invasive surfactant administration in preterm infants
Prädiktoren für CPAP-Versagen nach weniger-invasiver Surfactant-Gabe bei Frühgeborenen
Frontiers in Pediatrics · 27.08.2024 · 12
DOI: 10.3389/fped.2024.1444906 ↗Auf einen Blick
Bei Frühgeborenen nach LISA trat CPAP-Versagen häufig auf und war mit Tod oder schwerer BPD verbunden. Gestationsalter, IUGR, Aufnahmetemperatur, SF-Ratio und LUS-Score waren die besten Prädiktoren.
Fragestellung
Welche Faktoren sagen CPAP-Versagen nach LISA bei Frühgeborenen voraus?
Methode
Beobachtungsstudie in 2 neonatologischen Level-III-Zentren; Frühgeborene von 23 0 bis 33 6 Wochen; Daten aus 2017–2022.
Ergebnisse
289 inborn preterm infants erhielten Surfactant, 174 mit LISA. CPAP-Versagen nach LISA trat bei 38 Patienten (21,8 %) auf und nahm mit dem GA ab. AUC 0,84 (95 %-KI 0,75–0,93).
Schlussfolgerung der Autor:innen
CPAP-Versagen nach LISA ist bei extrem Frühgeborenen weiterhin häufig und erhöht Tod oder Behinderung. Ärzt:innen sollten die Hauptrisikofaktoren berücksichtigen; LUS und SF-Ratio bei Aufnahme können hilfreich sein.
Kernaussagen
- CPAP-Versagen nach LISA: 38 Fälle (21,8 %)
- Beste Prädiktoren: GA, IUGR, Temperatur, SF-Ratio, LUS-Score
- Vorhersagemodell: AUC 0,84 (95 %-KI 0,75–0,93)
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 27.08.2024. Verfasst von Miguel Alsina-Casanova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Neonatology Department, Hospital Clínic Barcelona, BCNatal (Barcelona Center for Maternal-Fetal and Neonatal Medicine), Barcelona, Spain. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Neonatologie
Abstract (Originalsprache)
Introduction
Less-invasive surfactant administration (LISA) is associated with better respiratory outcomes in preterm infants with respiratory distress syndrome. However, mechanical ventilation (MV) shortly after the LISA procedure has been related to lower survival. This study aimed to analyze the trends and main predictors of continuous positive airway pressure (CPAP) failure after LISA. Material and methods Preterm infants born between 23 0 and 33 6 weeks gestational age (GA) in two level III neonatal units who received surfactant were included (2017–2022). Demographic data, lung ultrasound (LUS) scores, the saturation/fraction of inspired oxygen (SF) ratio, technique, time to surfactant administration, and the main neonatal outcomes were collected.
Results
Over the study period, 289 inborn preterm infants received surfactant, 174 with the LISA method (60.2%). Patients who received surfactant after intubation in the delivery room ( n = 56) were more immature and exhibited worse outcomes. Patients who received surfactant via an endotracheal tube in the neonatal intensive care unit ( n = 59) had higher LUS scores and a lower SF ratio than those treated with LISA. The LISA method was associated with less death or bronchopulmonary dysplasia (BPD), with an adjusted odds ratio (aOR) = 0.37 [95% confidence interval (CI), 0.18–0.74, p = 0.006]. CPAP failure after LISA (defined as the need for intubation and MV in the first 72 h of life) occurred in 38 patients (21.8%), inversely proportional to GA (38.7% at 23–26 weeks, 26.3% at 27–30 weeks, and 7.9% at 30–33 weeks ( p < 0.001). CPAP failure after LISA was significantly related to death, with an aOR = 12.0 (95% CI, 3.0–47.8, p < 0.001), and moderate to severe BPD, with an aOR = 2.9 (95% CI, 1.1–8.0, p = 0.035), when adjusting for GA. The best predictors of CPAP failure after LISA were GA, intrauterine growth restriction, temperature at admission, the SF ratio, and the LUS score, with a Nagelkerke's R 2 = 0.458 ( p < 0.001). The predictive model showed an area under the curve = 0.84 (95% CI, 0.75–0.93, p < 0.001).
Conclusions
CPAP failure after LISA is still common in extremely preterm infants, leading to an increase in death or disability. Clinicians must acknowledge the main risk factors of CPAP failure to choose wisely the right patient and the best technique. LUS and the SF ratio at admission can be useful when making these decisions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neonatology Department, Hospital Clínic Barcelona, BCNatal (Barcelona Center for Maternal-Fetal and Neonatal Medicine), Barcelona, Spain.
- Neonatology Department, Hospital Sant Joan de Déu, BCNatal (Barcelona Center for Maternal-Fetal and Neonatal Medicine), Barcelona, Spain.
- Pediatrics Department, Hospital Sant Joan de Déu, Barcelona, Spain.
Zitieren
APA
Alsina-Casanova, M., Brito, N., Balcells-Esponera, C., Herranz-Barbero, A., Teresa-Palacio, M., Soler-García, A., Agustí, C., Brullas, G., Clotet, J., Carrasco, C., Salvia, D., & Aldecoa-Bilbao, V. (2024). Predictors of CPAP failure after less-invasive surfactant administration in preterm infants. Frontiers in Pediatrics, 12. https://doi.org/10.3389/fped.2024.1444906
Vancouver
Alsina-Casanova M, Brito N, Balcells-Esponera C, Herranz-Barbero A, Teresa-Palacio M, Soler-García A, et al. Predictors of CPAP failure after less-invasive surfactant administration in preterm infants. Frontiers in Pediatrics. 2024;12. doi:10.3389/fped.2024.1444906
BibTeX
@article{AlsinaCasanova2024,
author = {Alsina-Casanova, Miguel and Brito, Nerea and Balcells-Esponera, Carla and Herranz-Barbero, Ana and Teresa-Palacio, Marta and Soler-García, Aleix and Agustí, Carmen and Brullas, Guillem and Clotet, Jordi and Carrasco, Cristina and Salvia, Dolors and Aldecoa-Bilbao, Victoria},
title = {Predictors of CPAP failure after less-invasive surfactant administration in preterm infants},
journal = {Frontiers in Pediatrics},
year = {2024},
volume = {12},
doi = {10.3389/fped.2024.1444906}
}
EUVIMED